These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12239092)

  • 1. Evaluation of neuromedin U actions in energy homeostasis and pituitary function.
    Ivanov TR; Lawrence CB; Stanley PJ; Luckman SM
    Endocrinology; 2002 Oct; 143(10):3813-21. PubMed ID: 12239092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central effects of neuromedin U in the regulation of energy homeostasis.
    Nakazato M; Hanada R; Murakami N; Date Y; Mondal MS; Kojima M; Yoshimatsu H; Kangawa K; Matsukura S
    Biochem Biophys Res Commun; 2000 Oct; 277(1):191-4. PubMed ID: 11027662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative energy balance and leptin regulate neuromedin-U expression in the rat pars tuberalis.
    Nogueiras R; Tovar S; Mitchell SE; Barrett P; Rayner DV; Dieguez C; Williams LM
    J Endocrinol; 2006 Aug; 190(2):545-53. PubMed ID: 16899587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central administration of neuromedin U activates neurons in ventrobasal hypothalamus and brainstem.
    Niimi M; Murao K; Taminato T
    Endocrine; 2001 Dec; 16(3):201-6. PubMed ID: 11954664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothalamic actions of neuromedin U.
    Wren AM; Small CJ; Abbott CR; Jethwa PH; Kennedy AR; Murphy KG; Stanley SA; Zollner AN; Ghatei MA; Bloom SR
    Endocrinology; 2002 Nov; 143(11):4227-34. PubMed ID: 12399416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of physiological functions between neuromedin U-related peptide and neuromedin S-related peptide in the rat central nervous system.
    Tanaka Y; Taguchi S; Maruyama K; Mori K; Miyazato M; Kangawa K; Murakami N; Nakahara K
    Biochem Biophys Res Commun; 2021 Jan; 534():653-658. PubMed ID: 33228964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterisation of four cDNAs encoding neuromedin U (NMU) from the brain and gut of goldfish, and the inhibitory effect of a deduced NMU on food intake and locomotor activity.
    Maruyama K; Konno N; Ishiguro K; Wakasugi T; Uchiyama M; Shioda S; Matsuda K
    J Neuroendocrinol; 2008 Jan; 20(1):71-8. PubMed ID: 18081554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative regulation of neuromedin U mRNA expression in the rat pars tuberalis by melatonin.
    Aizawa S; Sakata I; Nagasaka M; Higaki Y; Sakai T
    PLoS One; 2013; 8(7):e67118. PubMed ID: 23843987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromedin U suppresses prolactin secretion via dopamine neurons of the arcuate nucleus.
    Nakahara K; Maruyama K; Ensho T; Mori K; Miyazato M; Kangawa K; Uemura R; Sakoda H; Nakazato M; Murakami N
    Biochem Biophys Res Commun; 2020 Jan; 521(2):521-526. PubMed ID: 31677791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRL-releasing peptide interacts with leptin to reduce food intake and body weight.
    Ellacott KL; Lawrence CB; Rothwell NJ; Luckman SM
    Endocrinology; 2002 Feb; 143(2):368-74. PubMed ID: 11796488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of the hypothalamic paraventricular nucleus to the locomotor-activating effects of neuromedin U in obesity.
    Novak CM; Zhang M; Levine JA
    Brain Res; 2007 Sep; 1169():57-68. PubMed ID: 17706946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of galanin-like peptide on energy balance, body temperature and brain activity in the mouse and rat are independent of the GALR2/3 receptor.
    Man PS; Lawrence CB
    J Neuroendocrinol; 2008 Jan; 20(1):128-37. PubMed ID: 18081561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of motivation for food by neuromedin U in the paraventricular nucleus and the dorsal raphe nucleus.
    McCue DL; Kasper JM; Hommel JD
    Int J Obes (Lond); 2017 Jan; 41(1):120-128. PubMed ID: 27748746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central actions of neuromedin U via corticotropin-releasing hormone.
    Hanada T; Date Y; Shimbara T; Sakihara S; Murakami N; Hayashi Y; Kanai Y; Suda T; Kangawa K; Nakazato M
    Biochem Biophys Res Commun; 2003 Nov; 311(4):954-8. PubMed ID: 14623274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fos expression in CRF-containing neurons in the rat paraventricular nucleus after central administration of neuromedin U.
    Yokota M; Ozaki Y; Sakamoto F; Yamada S; Saito J; Fujihara H; Ueta Y
    Stress; 2004 Jun; 7(2):109-12. PubMed ID: 15512854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats.
    Gartlon J; Szekeres P; Pullen M; Sarau HM; Aiyar N; Shabon U; Michalovich D; Steplewski K; Ellis C; Elshourbagy N; Duxon M; Ashmeade TE; Harrison DC; Murdock P; Wilson S; Ennaceur A; Atkins A; Heidbreder C; Hagan JJ; Hunter AJ; Jones DN
    Psychopharmacology (Berl); 2004 Dec; 177(1-2):1-14. PubMed ID: 15205870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of feeding suppression by the anorexigenic hormones neuromedin U and neuromedin S in rats.
    Nakahara K; Katayama T; Maruyama K; Ida T; Mori K; Miyazato M; Kangawa K; Murakami N
    J Endocrinol; 2010 Nov; 207(2):185-93. PubMed ID: 20732934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromedin U-deficient rats do not lose body weight or food intake.
    Yokogi K; Goto Y; Otsuka M; Ojima F; Kobayashi T; Tsuchiba Y; Takeuchi Y; Namba M; Kohno M; Tetsuka M; Takeuchi S; Matsuyama M; Aizawa S
    Sci Rep; 2022 Oct; 12(1):17472. PubMed ID: 36302800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct functions of neuromedin u and neuromedin s in orange-spotted grouper.
    Li S; Xiao L; Liu Q; Zheng B; Chen H; Liu X; Zhang Y; Lin H
    J Mol Endocrinol; 2015 Oct; 55(2):95-106. PubMed ID: 26162607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice.
    Kaisho T; Nagai H; Asakawa T; Suzuki N; Fujita H; Matsumiya K; Nishizawa N; Kanematsu-Yamaki Y; Dote K; Sakamoto JI; Asami T; Takekawa S
    Int J Obes (Lond); 2017 Dec; 41(12):1790-1797. PubMed ID: 28757640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.